Shareholder Value and Financial Outlook

2023 FULL YEAR GUIDANCE* EPS REVENUE & MEDICAL CUSTOMERS KEY RATIOS Adjusted EPS At least $24.60 Adjusted revenues At least $187,000M Medical care ratio 81.5% -82.5% Total medical customer growth At least 1.2M Adjusted SG&A expense -7.3% ratio ADJUSTED INCOME FROM OPERATIONS Enterprise, after tax At least $7,330M Adjusted effective tax rate 21.0% -21.5% CAPITAL DEPLOYMENT Cash flow from operations At least $9,000M Evernorth, pre-tax At least $6,400M Cigna Healthcare, pre-tax Weighted average shares outstanding 296M - 300M At least $4,400M *Cigna's outlook for full year 2023 includes the expected impacts of the FASB's new accounting for Long-Duration Insurance Contracts ("LDTI") that is required to be adopted on January 1, 2023. The adoption of LDTI is not expected to result in a material restatement of Cigna's results in prior periods. Confidental unpublished property of igra.2028 Ogna

View entire presentation